LLY - Lilly extends tender offer for POINT Biopharma to Dec. 22
2023-12-18 11:44:54 ET
More on Eli Lilly
- Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly
- Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Conference (Transcript)
- Eli Lilly: Perfectly Priced Healthcare Giant
- Lantheus, Point BioPharma drop amid results of SPLASH study on prostate cancer
- Ken Langone: Eli Lilly will be the first trillion-dollar drug company
For further details see:
Lilly extends tender offer for POINT Biopharma to Dec. 22